Biologics–our new study reveals trends, R&D progress, and predicted revenues
Where is the Biologics market heading? If you are involved in this sector you must read this newly updated report. The report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 710+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biologics Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT, Porter’s, PEST Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

By Product Type

Monoclonal Antibodies

  • Humira
  • Remicide
  • Tysabri
  • Herceptin
  • Kadcyla
  • Perjeta
  • Opdivo
  • Keytruda
  • Avastin

Vaccines

Protein Therapeutics

Insulin:

  • Lantus
  • Novolog/NovoRapid
  • Humalog
  • Levemir

Apidra

  • Other Recombinant Hormones
  • Plasma & Recombinant Coagulation Factors

Interferons:

  • Avonex
  • Rebif
  • Enzyme Replacement & Other Protein Therapies

Regenerative Medicines

Stem Cell Therapy:

  • Osteocel Plus
  • Trinity Evolution & Trinity Elite


Tissue Engineered Products:

  • Apligraft
  • Demagraft


Gene Therapies (IMIGYLC)

Fusion Proteins

  • Enbrel
  • Eylea

By Application

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Disorders
  • Haematological Disorders
  • Others

By Manufacturing

  • Outsourced
  • In-house

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

By Region

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Leading companies and the potential for market growth
Overall world revenue for Biologics Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biologics Market report helps you
In summary, our 710+ page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Biologics Market, with forecasts for Product Type, Application and Manufacturing, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 16 key national markets – See forecasts for the Biologics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, GCC Countries and South Africa.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 23 of the major companies involved in the Biologics Market. Some of the company’s profiles in this report include GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi S.A., Novo Nordisk A/S, Takeda Pharmaceutical, Gilead Sciences, Regeneron Pharmaceuticals, Inc., Biogen, AbbVie, and Amgen among other prominent players

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.